Toll Free: 1-888-928-9744

Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016

Published: Apr 15, 2016 | Pages: 162 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016" provides an overview of Cardiovascular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiovascular Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Cardiovascular Inflammation Therapeutics Clinical Trials 28 Prominent Drugs 30 Clinical Trial Profile Snapshots 31 Appendix 159 Abbreviations 159 Definitions 159 Research Methodology 160 Secondary Research 160 About GlobalData 161 Contact Us 161 Disclaimer 161 Source 162
List of Tables
Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Region, 2016* 6 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Cardiovascular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Cardiovascular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Cardiovascular Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Cardiovascular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Cardiovascular Inflammation Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Cardiovascular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Cardiovascular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Cardiovascular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Cardiovascular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Cardiovascular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Cardiovascular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Cardiovascular Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Cardiovascular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Cardiovascular Inflammation Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Cardiovascular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Cardiovascular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Cardiovascular Inflammation to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Cardiovascular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Cardiovascular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Cardiovascular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 160

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify